Clinical Trials
9
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Evaluation of Nitric Oxide Nasal Spray (NONS) for Treatment of Recurrent Acute Rhinosinusitis
- Conditions
- Recurrent Acute Rhinosinusitis
- Interventions
- Drug: Nitric Oxide Releasing SolutionDevice: Nasal spray with isotonic saline
- First Posted Date
- 2024-02-16
- Last Posted Date
- 2025-01-06
- Lead Sponsor
- Sanotize Research and Development corp.
- Target Recruit Count
- 162
- Registration Number
- NCT06264141
- Locations
- 🇨🇦
Okanegan Clinical Trials, Kelowna, British Columbia, Canada
🇨🇦Richmond Clinical Trials (Okanagan Clinical Trials Satelite Site), Richmond, British Columbia, Canada
🇨🇦Cliantha Research, Mississauga, Ontario, Canada
Nitric Oxide Releasing Mouthwash (NORM) for the Management of Oropharyngeal Candidiasis
- First Posted Date
- 2023-11-07
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- Sanotize Research and Development corp.
- Target Recruit Count
- 6
- Registration Number
- NCT06120816
- Locations
- 🇨🇦
Atlantis Dental Cambie, Vancouver, British Columbia, Canada
Nitric Oxide Releasing Solution (NORS) For The Treatment Of Human Papillomavirus(HPV) Verrucae Plantaris (Plantar Warts)
- Conditions
- Verruca Plantaris
- Interventions
- Other: Sterile water foot bath
- First Posted Date
- 2023-05-26
- Last Posted Date
- 2024-04-17
- Lead Sponsor
- Sanotize Research and Development corp.
- Target Recruit Count
- 20
- Registration Number
- NCT05877313
- Locations
- 🇨🇦
Achilles Foot Health Centre, Surrey, British Columbia, Canada
🇨🇦Spectrum Health, Vancouver, British Columbia, Canada
🇨🇦Pacific Derm, Vancouver, British Columbia, Canada
Nitric Oxide Nasal Spray (NONS) To Treat and Prevent the Exacerbation of Infection in Individuals With Mild COVID-19
- First Posted Date
- 2022-10-31
- Last Posted Date
- 2022-10-31
- Lead Sponsor
- Sanotize Research and Development corp.
- Target Recruit Count
- 306
- Registration Number
- NCT05599919
- Locations
- 🇮🇳
Ishwar Institute & Hospital, Aurangabad, India
🇮🇳MGM Medical College & Hospital, Aurangabad, India
🇮🇳Bangalore Medical College and Research Institute, Bangalore, India
Nitric Oxide Nasal Spray (NONS) as Prevention for Treatment of Individuals at Risk of Exposure to COVID-19 Infection
- Conditions
- SARS-CoV-2 Infection
- Interventions
- Device: Nasal spray with isotonic saline
- First Posted Date
- 2021-11-05
- Last Posted Date
- 2023-05-06
- Lead Sponsor
- Sanotize Research and Development corp.
- Target Recruit Count
- 1389
- Registration Number
- NCT05109611
- Locations
- 🇨🇦
Medical Trust Clinics , Inc, Oshawa, Ontario, Canada
🇱🇰National Institute of Infectious Diseases Hospital, Angoda, Angoda, Sri Lanka
🇱🇰Karapitiya teaching Hospital,, Galle, Sri Lanka
- Prev
- 1
- 2
- Next